88 related articles for article (PubMed ID: 17119008)
1. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia.
Ishida K; Mitoma H; Wada Y; Oka T; Shibahara J; Saito Y; Murayama S; Mizusawa H
J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):190-2. PubMed ID: 17119008
[TBL] [Abstract][Full Text] [Related]
2. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
3. "Hot Cross Bun" Sign in a Patient with Glutamic Acid Decarboxylase 65-KDa Isoform Associated Cerebellar Ataxia: Case Report and Review of the Literature.
Duan RN; He JZ; Cao LL
Cerebellum; 2024 Jun; 23(3):1204-1210. PubMed ID: 37948023
[TBL] [Abstract][Full Text] [Related]
4. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
[TBL] [Abstract][Full Text] [Related]
5. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
[TBL] [Abstract][Full Text] [Related]
6. Lesson of the month 2: Autoimmune sequelae of anti-GAD antibodies - thinking outside the box.
Ward RJ; Varughese GI; Jose B; Abraham RJ
Clin Med (Lond); 2017 Oct; 17(5):473-474. PubMed ID: 28974603
[TBL] [Abstract][Full Text] [Related]
7. Anti-glutamic Acid decarboxylase antibody-associated ataxia as an extrahepatic autoimmune manifestation of hepatitis C infection: a case report.
Awad A; Stüve O; Mayo M; Alkawadri R; Estephan B
Case Rep Neurol Med; 2011; 2011():975152. PubMed ID: 22937348
[TBL] [Abstract][Full Text] [Related]
8. Teaching Video NeuroImage: Adaptor-Related Protein-Complex-3 Subunit β-2 Immunoglobulin-G-Associated Autoimmune Ataxia.
Kothapalli NP; Chompoopong P; McKeon A; Dubey D
Neurology; 2024 Apr; 102(7):e209257. PubMed ID: 38489556
[No Abstract] [Full Text] [Related]
9. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.
Manto MU; Laute MA; Aguera M; Rogemond V; Pandolfo M; Honnorat J
Ann Neurol; 2007 Jun; 61(6):544-51. PubMed ID: 17600364
[TBL] [Abstract][Full Text] [Related]
10. The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy.
Hou JY; Liu HU; Kuo CY; Liu YH; Lin JJ; Hsieh MY; Hung PC; Cheng YT; Su IC; Wang HS; Chou IJ; Lin KL
Front Neurosci; 2022; 16():1081580. PubMed ID: 36817097
[TBL] [Abstract][Full Text] [Related]
11. Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex.
Tröscher AR; Mair KM; Verdú de Juan L; Köck U; Steinmaurer A; Baier H; Becker A; Blümcke I; Finzel M; Geis C; Höftberger R; Mawrin C; von Oertzen TJ; Pitsch J; Surges R; Voges B; Weis S; Winklehner M; Woermann F; Bauer J; Bien CG
Brain; 2023 Apr; 146(4):1436-1452. PubMed ID: 36314080
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Clinical Features in Autoimmune-Mediated Movement Disorders.
Hsieh PC; Wu YR
J Mov Disord; 2022 May; 15(2):95-105. PubMed ID: 35670020
[TBL] [Abstract][Full Text] [Related]
13. A Breakdown of Immune Tolerance in the Cerebellum.
Hampe CS; Mitoma H
Brain Sci; 2022 Feb; 12(3):. PubMed ID: 35326284
[TBL] [Abstract][Full Text] [Related]
14. Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies.
Dalakas MC
Neurotherapeutics; 2022 Apr; 19(3):832-847. PubMed ID: 35084720
[TBL] [Abstract][Full Text] [Related]
15. Advances in the Pathogenesis of Auto-antibody-Induced Cerebellar Synaptopathies.
Mitoma H; Manto M
Cerebellum; 2023 Feb; 22(1):129-147. PubMed ID: 35064896
[TBL] [Abstract][Full Text] [Related]
16. Novelties in Autoimmune and Paraneoplastic Cerebellar Ataxias: Twenty Years of Progresses.
Muñiz-Castrillo S; Vogrig A; Ciano-Petersen NL; Villagrán-García M; Joubert B; Honnorat J
Cerebellum; 2022 Aug; 21(4):573-591. PubMed ID: 35020135
[TBL] [Abstract][Full Text] [Related]
17. Brain and Muscle Metabolic Changes by FDG-PET in Stiff Person Syndrome Spectrum Disorders.
Wang Y; Sadaghiani MS; Tian F; Fitzgerald KC; Solnes L; Newsome SD
Front Neurol; 2021; 12():692240. PubMed ID: 34603180
[No Abstract] [Full Text] [Related]
18. GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.
Tsiortou P; Alexopoulos H; Dalakas MC
Ther Adv Neurol Disord; 2021; 14():17562864211003486. PubMed ID: 33854562
[TBL] [Abstract][Full Text] [Related]
19. Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms.
Mitoma H; Manto M; Hadjivassiliou M
J Mov Disord; 2021 Jan; 14(1):10-28. PubMed ID: 33423437
[TBL] [Abstract][Full Text] [Related]
20. Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.
Mitoma H; Honnorat J; Yamaguchi K; Manto M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
